JPMORGAN CHASE & CO - PROTAGONIST THERAPEUTICS INC ownership

Back to all holdings Add to watchlist

PROTAGONIST THERAPEUTICS INC's ticker is and the CUSIP is 74366E902. A total of 4 filers reported holding PROTAGONIST THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Links
Filings
Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of PROTAGONIST THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,668,000
-77.5%
100,000
-62.7%
0.00%
-100.0%
Q2 2023$7,402,160
+20.9%
268,000
+3.7%
0.00%0.0%
Q1 2022$6,121,000
+3358.2%
258,500
+2485.0%
0.00%–
Q3 2021$177,000–10,000–0.00%–
 Download
Other shareholders
PROTAGONIST THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
GROUP ONE TRADING, L.P. 100,700$797,0000.00%
SIMPLEX TRADING, LLC 37,100$293,0000.00%
JANE STREET GROUP, LLC 22,600$179,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of PROTAGONIST THERAPEUTICS INC shareholders